In vitro experiments have demonstrated that suppression of NFE2L3 inhibits cell proliferation, migration, invasion, and EMT, ultimately leading to apoptosis in liver cancer cells (Yu et al., 2019; Ren Y. et al., 2020). This evidence concerns the gene NFE2L3 and liver cancer.